About Us-TriApex

To be a next-generation CRO that enables new drug R&D through integrated and disease biology-driven solutions.

group profile

Dedicated to empowering pharmaceutical companies and research institutions worldwide through integrated, disease biology–driven R&D solutions.

Founded in 2008, we are a next-generation CRO dedicated to empowering pharmaceutical enterprises and research institutions worldwide through integrated, disease biology–driven R&D solutions.

We provide a comprehensive suite of nonclinical safety, efficacy and DMPK studies, alongside integrated clinical trial services spanning POC to pivotal trials, supporting our clients throughout the R&D lifecycle.

Vision

To be a next-generation CRO that enables new drug R&D through integrated and disease biology-driven solutions.

Missions

Dedicated to scientific assessment, innovation translation, and life quality improvement.

Values

Integrity Dedication Cooperation Excellence

Partners

Through close collaboration, we have established a loyal, diverse and high-quality client base, including commercial-stage pharmaceutical companies, early-stage biotechs and renowned research institutions across the world.

700 +

Nonclinical clients

130 +

Clinical clients

220 +

Approvals form NMPA

40 +

Approvals form overseas regulatory agencies